Nuklearmedizin - NuclearMedicine, Table of Contents Nuklearmedizin 2006; 45(06): N64-N66DOI: 10.1055/s-0038-1625107 Originalarbeiten – Original Articles Schattauer GmbH Necrobiotic panniculitis due to repeated insulin injection: a rare cause of a false positive somatostatin receptor scintigraphy G. Zettinig 1 Department of Nuclear Medicine , F. Wrba 2 Department of Pathology , F. Trautinger 3 Department of Dermatology , P. Peloschek 4 Department of Radiology , A. Luger 5 Department of Internal Medicine III, Medical University of Vienna, Austria › Author Affiliations Recommend Article Abstract Buy Article Full Text References References 1 Balon HR, Goldsmith SJ, Siegel BA. et al. Procedure guideline for somatostatin receptor scintigraphy with 111In-pentetreotide. J Nucl Med 2001; 42: 1134-8. 2 Degirmenci B, Bekis R, Sen M. et al. Indium-111 octreotide uptake in the surgical scar. Nuklearmedizin 1999; 38: 306-8. 3 Forster GJ, Krummenauer F, Nickel O. et al. Somatostatin- receptor scintigraphy in Graves’ disease: reproducibility and variance of orbital activity. Cancer Biother Radiopharm 2000; 15: 517-25. 4 Kainberger F, Kurtaran A, Kienast O. et al. Hybrid imaging for endocrine diseases: new perspectives. Wien Klin Wochenschr 2003; 115 (Suppl. 02) 87-90. 5 Ozer S, Dobrozemsky G, Kienast O. et al. Value of combined XCT/SPECT technology for avoiding false positive planar 123I-MIBG scintigraphy. Nuklearmedizin 2004; 43: 164-70. 6 Reubi JC, Kvols E, Krenning E. et al. Distribution of somatostatin receptors in normal and tumor tissue. Metabolism 1990; 9: 78-81. 7 Virgolini I, Traub T, Novotny C. et al. Experience with indium-111 and yttrium-90-labeled somatostatin analogs. Curr Pharm Des 2002; 8: 1781-807.
